Current developments of gene therapy in human diseases
MedComm · 2024-09 · 5 (9)
DOI: 10.1002/mco2.645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 16.08.2024. Verfasst von Fanfei Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology West China Hospital Chengdu Sichuan China. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Gene therapy has witnessed substantial advancements in recent years, becoming a constructive tactic for treating various human diseases. This review presents a comprehensive overview of these developments, with a focus on their diverse applications in different disease contexts. It explores the evolution of gene delivery systems, encompassing viral (like adeno‐associated virus; AAV) and nonviral approaches, and evaluates their inherent strengths and limitations. Moreover, the review delves into the progress made in targeting specific tissues and cell types, spanning the eye, liver, muscles, and central nervous system, among others, using these gene technologies. This targeted approach is crucial in addressing a broad spectrum of genetic disorders, such as inherited lysosomal storage diseases, neurodegenerative disorders, and cardiovascular diseases. Recent clinical trials and successful outcomes in gene therapy, particularly those involving AAV and the clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR‐associated proteins, are highlighted, illuminating the transformative potentials of this approach in disease treatment. The review summarizes the current status of gene therapy, its prospects, and its capacity to significantly ameliorate patient outcomes and quality of life. By offering comprehensive analysis, this review provides invaluable insights for researchers, clinicians, and stakeholders, enriching the ongoing discourse on the trajectory of disease treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology West China Hospital Chengdu Sichuan China.
- State Key Laboratory of Biotherapy West China Hospital Chengdu Sichuan China.
- College of Life Sciences Sichuan University Chengdu Sichuan China.
ORCID-Profile: Yang Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Liu, F., Li, R., Zhu, Z., Yang, Y., & Lu, F. (2024). Current developments of gene therapy in human diseases. MedComm, 5(9). https://doi.org/10.1002/mco2.645
Vancouver
Liu F, Li R, Zhu Z, Yang Y, Lu F. Current developments of gene therapy in human diseases. MedComm. 2024;5(9). doi:10.1002/mco2.645
BibTeX
@article{Liu2024,
author = {Liu, Fanfei and Li, Ruiting and Zhu, Zilin and Yang, Yang and Lu, Fang},
title = {Current developments of gene therapy in human diseases},
journal = {MedComm},
year = {2024},
volume = {5},
number = {9},
doi = {10.1002/mco2.645}
}
EUVIMED